| Identification | Back Directory | [Name]
N1-Methyl-N3-[(2S)-2-(t-butoxycarbonyl)amino-3-(t-butoxycarbonyl)] propylpseudouridine | [CAS]
1613530-24-7 | [Synonyms]
N1-Methyl-N3-[(2S)-2-(t-butoxycarbonyl)amino-3-(t-butoxycarbonyl)] propylpseudouridine
1(2H)-Pyrimidinebutanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-3,6-dihydro-3-methyl-2,6-dioxo-5-β-D-ribofuranosyl-, 1,1-dimethylethyl ester, (βS)- | [Molecular Formula]
C23H37N3O10 | [MDL Number]
MFCD31707435 | [MOL File]
1613530-24-7.mol | [Molecular Weight]
515.56 |
| Hazard Information | Back Directory | [Uses]
N1-Methyl-N3-[(2S)-2-(t-butoxycarbonyl)amino-3-(t-butoxycarbonyl)] propylpseudouridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|